Prostate Grand Rounds – Steubenville, OH
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
12 events found.
CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Brooklyn, NY
The Brooklyn Hospital Center 121 DeKalb Avenue, Brooklyn, NY, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
Hemophilia A Grand Rounds
This case-based live activity will cover the treatment and management of patients with hemophilia A
CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Hoboken, NJ
Hoboken University Medical Center 308 Willow Ave, Hoboken, NJ, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
A 3D View of Genomics, Targeted Therapeutic Options, and Treatment Sequencing for the Management of Hematologic Malignancies – Oxnard, CA
This activity will cover the treatment and management of patients with AML and CLL.
Hemophilia A – Augusta, ME
This case-based live activity will cover the treatment and management of patients with hemophilia A
Atopic Derm – Nashville, TN
Meharry Medical College 1005 Dr. D.B.Todd Jr. Blvd, Nashville, TN, United StatesThis activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.
A 3D View of Genomics, Targeted Therapeutic Options, and Treatment Sequencing for the Management of Hematologic Malignancies – Nashville, TN
This activity will cover the treatment and management of patients with AML and CLL.
Atopic Derm – Philadelphia, PA
This activity is intended educate PCPs, NPs, and PAs about diagnosing, treating, and managing atopic dermatitis in pediatric patients.
Prostate Grand Rounds – Clarksburg, WV
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
axSpA GR – Grand Blanc, MI
This activity is primarily designed for U.S.-based members of multidisciplinary teams involved in the management of patients with Axial Spondyloarthritis.
CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Jamaica, NY
NYC Health + Hospitals/Queens 82-68 164th Street Main-bldg, 5th Floor, Conference Room A540, Jamaica, NY, United StatesThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.